恶性卵巢和丸生殖细胞瘤:共同的特征但不同的预后
Camilla Sköld1, Anna K Jansson1, Ingrid Glimelius1,2
1Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden.
Journal of internal medicine
|March 12, 2024
概括
卵巢和丸中的生殖细胞瘤 (GCTs) 具有相似之处,但在预后上有所不同. 本综述探讨了丸GCT治疗的见解,以改善卵巢GCT结果并减少副作用.
科学领域:
- 在瘤学瘤学.
- 生殖医学 生殖医学
- 癌症研究 癌症研究
背景情况:
- 卵巢和丸生殖细胞瘤 (GCTs) 起源于原始生殖细胞,影响年轻患者,对基于思的治疗反应良好.
- 尽管有相似之处,卵巢GCT与丸GCT相比 (85.2%的5年生存率) 的预后较差 (98.2%),部分原因是发生率较低,卵巢GCT的指导方针较少.
- 卵巢和丸GCT之间存在疾病传播,分期和治疗建议的差异.
研究的目的:
- 审查丸GCT (精子瘤和非精子瘤) 的病因学,瘤生物学和临床知识.
- 从丸GCT管理中获得见解,为卵巢GCT提供信息并建议改善行动.
- 假设采用丸GCT治疗策略可以提高卵巢GCT预后,并最大限度地减少长期副作用.
主要方法:
- 瑞典丸 (1995-2022) 和卵巢 (1990-2018) GCT患者的生存数据的比较综述.
- 对丸GCT特有的病因学,瘤生物学和临床知识的分析.
- 基于丸GCT证据的卵巢GCT治疗策略建议的制定.
主要成果:
- 与卵巢GCT (85.2%) 相比,丸GCT显示出明显更高的5年整体存活率 (98.2%).
- 卵巢GCT的发病率较低,与丸GCT相比,导致知识,经验和证据较不发达.
- 现有的数据突出显示了生存率的差异,强调了对卵巢GCT优化治疗方案的需要.
结论:
- 从丸GCT管理中采用特定的治疗策略,例如对低风险患者减缓辅助化疗,可能有利于卵巢GCT患者.
- 实施用于复发性卵巢GCT的标准化和密集治疗方案,反映丸GCT方法,可能会改善结果.
- 进一步的研究和指导方针的制定至关重要,以提高预后,并通过利用丸GCT的知识来最大限度地减少卵巢GCT患者的长期副作用.
相关概念视频
Disorders of the Male Reproductive System
414
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
414
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K


